TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media
Download Report PDF Instantly
Report overview
The global Non-Invasive Blood Glucose Monitoring System market was valued at USD 131.48 million in 2023 and is projected to reach USD 375.21 million by 2030, growing at a Compound Annual Growth Rate (CAGR) of 15.2% during the forecast period (2024-2030).
A non-invasive blood glucose monitoring system is a device or technology that measures blood glucose levels without the need for pricking the skin. It typically uses techniques such as near-infrared spectroscopy, electromagnetic sensors, or other non-invasive methods to estimate glucose levels, offering a more convenient alternative for diabetes management.
Technological Advancements: Growth in the market is driven by continuous advancements in non-invasive blood glucose monitoring technologies, such as optical coherence tomography (OCT), spectroscopy, and transdermal sensing methods.
Diabetes Management: Non-invasive blood glucose monitoring systems provide convenient and pain-free alternatives to traditional invasive methods, enhancing patient compliance and improving quality of life.
Increasing Diabetes Prevalence: Rising prevalence of diabetes globally, coupled with the need for frequent blood glucose monitoring, fuels the demand for non-invasive monitoring solutions.
Patient Preference: Growing preference among patients for non-invasive monitoring systems due to comfort, ease of use, and avoidance of complications associated with invasive methods.
Regulatory Considerations: Regulatory approvals and adherence to quality standards play a crucial role in the market's growth trajectory, influencing product availability and adoption.
Healthcare Infrastructure: Improvements in healthcare infrastructure, particularly in emerging markets, contribute to increased adoption of non-invasive blood glucose monitoring systems.
Competitive Landscape: Key players in the market are focusing on research and development to innovate new technologies, strategic partnerships, and geographical expansion to gain a competitive edge.
Challenges: Challenges such as accuracy of non-invasive measurements compared to traditional methods, regulatory hurdles, and pricing pressures may affect market dynamics.
The global key manufacturers of Non-Invasive Blood Glucose Monitoring System include Abbott Laboratories, Medtronic plc, F. Hoffmann-La Roche Ltd., Ascensia Diabetes Care, Dexcom, Inc., Sanofi Novo Nordisk, Insulet Corporation, Ypsomed Holdings and Glysens Incorporated, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Non-Invasive Blood Glucose Monitoring System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-Invasive Blood Glucose Monitoring System. This report contains market size and forecasts of Non-Invasive Blood Glucose Monitoring System in global, including the following market information:
We has surveyed the Non-Invasive Blood Glucose Monitoring System manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Non-Invasive Blood Glucose Monitoring System Market, by Type, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Non-Invasive Blood Glucose Monitoring System Market Segment Percentages, by Type, 2023 (%)
Global Non-Invasive Blood Glucose Monitoring System Market, by Application, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Non-Invasive Blood Glucose Monitoring System Market Segment Percentages, by Application, 2023 (%)
Global Non-Invasive Blood Glucose Monitoring System Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Non-Invasive Blood Glucose Monitoring System Market Segment Percentages, By Region and Country, 2023 (%)
Competitor Analysis
The report also provides analysis of leading market participants including:
Further, the report presents profiles of competitors in the market, key players include:
Outline of Major Chapters:
Chapter 1: Introduces the definition of Non-Invasive Blood Glucose Monitoring System, market overview.
Chapter 2: Global Non-Invasive Blood Glucose Monitoring System market size in revenue and volume.
Chapter 3: Detailed analysis of Non-Invasive Blood Glucose Monitoring System manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Non-Invasive Blood Glucose Monitoring System in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Non-Invasive Blood Glucose Monitoring System capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
